Abstract BACKGROUND. Triple‐negative breast cancer (estrogen receptor‐negative, progesterone receptor‐negative, and HER2‐negative) is a high risk breast cancer that lacks the benefit of specific therapy that targets these proteins. METHODS. In this study, the authors examined a large and well charac...
No comments yet
Be the first to share your thoughts!